To date, targeting of chemokine receptors such as CCR2, CCR5, CCR6, CXCR3, CXCR4 and CX3CR1 by gene disruption or antagonistic peptides has been found to protect animals from DSS colitis [35], [36], [37], [38], [39]. This evidence concerns the gene CXCR4 and colitis.